CASIA OpenIR
(本次检索基于用户作品认领结果)

浏览/检索结果: 共5条,第1-5条 帮助

限定条件            
已选(0)清除 条数/页:   排序方式:
Peptidic microarchitecture-trapped tumor vaccine combined with immune checkpoint inhibitor or PI3K gamma inhibitor can enhance immunogenicity and eradicate tumors 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 卷号: 10, 期号: 2, 页码: 13
作者:  Du, Yang;  Liu, Ye;  Wang, Di;  Bai, Hua;  Wang, Zhijie;  He, Xiran;  Zhang, Pei;  Tian, Jie;  Wang, Jie
收藏  |  浏览/下载:220/0  |  提交时间:2022/06/06
immunotherapy  immunogenicity  vaccine  tumor microenvironment  lymphocytes  tumor infiltrating  macrophages  
ImmunoAIzer: A Deep Learning-Based Computational Framework to Characterize Cell Distribution and Gene Mutation in Tumor Microenvironment 期刊论文
CANCERS, 2021, 卷号: 13, 期号: 7, 页码: 21
作者:  Bian, Chang;  Wang, Yu;  Lu, Zhihao;  An, Yu;  Wang, Hanfan;  Kong, Lingxin;  Du, Yang;  Tian, Jie
Adobe PDF(14076Kb)  |  收藏  |  浏览/下载:280/24  |  提交时间:2021/05/17
deep learning  cell distribution  biomarker  tumor gene mutation  tumor microenvironment (TME)  semi-supervised learning  hematoxylin and eosin (H&  E)  
Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 11
作者:  Liang, Qian;  Kong, Lingxin;  Du, Yang;  Zhu, Xu;  Tian, Jie
Adobe PDF(2847Kb)  |  收藏  |  浏览/下载:463/104  |  提交时间:2019/12/16
Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect 期刊论文
EUROPEAN RADIOLOGY, 2019, 卷号: 29, 期号: 8, 页码: 4294-4302
作者:  Du, Yang;  Jin, Yinhua;  Sun, Wei;  Fang, Junjie;  Zheng, Jianjun;  Tian, Jie
收藏  |  浏览/下载:278/0  |  提交时间:2019/12/16
Cancer  Immunotherapy  Molecular imaging  Immune checkpoint target  
PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model 期刊论文
BMC CANCER, 2018, 卷号: 18, 页码: 7
作者:  Li, Yuan;  Du, Yang;  Sun, Ting;  Xue, Huadan;  Jin, Zhengyu;  Tian, Jie
浏览  |  Adobe PDF(4369Kb)  |  收藏  |  浏览/下载:444/193  |  提交时间:2019/02/18
PD-1  Zoledronic acid  Breast cancer  Therapy  Checkpoint inhibitior